(HealthDay News) -- Here are the latest clinical trials,
This study will evaluate the success of converting
opioid-experienced, chronic pain patients to a stable dose of
Embeda within six weeks. Candidates must be 21 or older, have had
least three months of moderate-to-severe pain, and be taking a
stable dose of an opioid drug.
The research site is in Sacramento, Calif.
This study will evaluate omega-3 acids for high-triglyceride
treatment, in combination with diet and exercise. Candidates must
have a history of high triglycerides of 500 to 1500, and may be
taking medication to lower cholesterol or triglycerides.
The research site is in Plano, Texas.
This phase 3b study will evaluate the cardiovascular safety of
febuxostat and allopurinol in people with gout and cardiovascular
problems. Candidates must have one or more of the American
Rheumatism Association criteria for the diagnosis of gout.
The research site is in Tamarac, Fla.
ClinicalConnection.com. All rights reserved.